These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 34861581)
1. MicroRNA-4317 suppresses the progression of hepatocellular carcinoma by targeting ZNF436-mediated PI3K/AKT signaling pathway. Zhang L; Chang S; Zhao Y; Cao G; Zhang D Tissue Cell; 2022 Feb; 74():101696. PubMed ID: 34861581 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway. Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399 [TBL] [Abstract][Full Text] [Related]
3. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway. Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway. Xu Q; Liu X; Liu Z; Zhou Z; Wang Y; Tu J; Li L; Bao H; Yang L; Tu K Mol Cancer; 2017 Jun; 16(1):103. PubMed ID: 28606154 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma. Liu Z; Wang Y; Dou C; Sun L; Li Q; Wang L; Xu Q; Yang W; Liu Q; Tu K J Exp Clin Cancer Res; 2018 Mar; 37(1):49. PubMed ID: 29510736 [TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA PICSAR/miR-588/EIF6 axis regulates tumorigenesis of hepatocellular carcinoma by activating PI3K/AKT/mTOR signaling pathway. Liu Z; Mo H; Sun L; Wang L; Chen T; Yao B; Liu R; Niu Y; Tu K; Xu Q; Yang N Cancer Sci; 2020 Nov; 111(11):4118-4128. PubMed ID: 32860321 [TBL] [Abstract][Full Text] [Related]
7. microRNA-1914, which is regulated by lncRNA DUXAP10, inhibits cell proliferation by targeting the GPR39-mediated PI3K/AKT/mTOR pathway in HCC. Sun L; Wang L; Chen T; Yao B; Wang Y; Li Q; Yang W; Liu Z J Cell Mol Med; 2019 Dec; 23(12):8292-8304. PubMed ID: 31576658 [TBL] [Abstract][Full Text] [Related]
8. SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma. Yang YF; Zhang MF; Tian QH; Fu J; Yang X; Zhang CZ; Yang H Mol Cancer; 2018 Aug; 17(1):117. PubMed ID: 30089483 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of miR-623 suppresses progression of hepatocellular carcinoma via regulating the PI3K/Akt signaling pathway by targeting XRCC5. Ren F; Su H; Jiang H; Chen Y J Cell Biochem; 2020 Jan; 121(1):213-223. PubMed ID: 31190447 [TBL] [Abstract][Full Text] [Related]
10. microRNA-206 prevents hepatocellular carcinoma growth and metastasis via down-regulating CREB5 and inhibiting the PI3K/AKT signaling pathway. Chi Y; Gong Z; Xin H; Wang Z; Liu Z Cell Cycle; 2022 Dec; 21(24):2651-2663. PubMed ID: 36003063 [TBL] [Abstract][Full Text] [Related]
11. KDM5A silencing transcriptionally suppresses the FXYD3-PI3K/AKT axis to inhibit angiogenesis in hepatocellular cancer via miR-433 up-regulation. Ma YS; Wu TM; Qian B; Liu YS; Ding H; Fan MM; Liu JB; Yu F; Wang HM; Shi Y; Gu LP; Li L; Tian LL; Wang PY; Wang GR; Wu ZJ; Zou QF; Ling CC; Fu D J Cell Mol Med; 2021 Apr; 25(8):4040-4052. PubMed ID: 33621431 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-517c Functions as a Tumor Suppressor in Hepatocellular Carcinoma via Downregulation of KPNA2 and Inhibition of PI3K/AKT Pathway. Ma L; Tao C; Zhang Y J Healthc Eng; 2022; 2022():7026174. PubMed ID: 35075389 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma. Zhang J; Cheng J; Zeng Z; Wang Y; Li X; Xie Q; Jia J; Yan Y; Guo Z; Gao J; Yao M; Chen X; Lu F Oncotarget; 2015 Dec; 6(39):42040-52. PubMed ID: 26547929 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1. Huang XP; Hou J; Shen XY; Huang CY; Zhang XH; Xie YA; Luo XL FEBS J; 2015 Feb; 282(3):579-94. PubMed ID: 25475121 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-148a Inhibits Hepatocellular Carcinoma Cell Growth via Epithelial-to-Mesenchymal Transition and PI3K/AKT Signaling Pathways by Targeting Death Receptor-5. Zhang N; Zhou J; Zhou Y; Guan F Appl Biochem Biotechnol; 2022 Jun; 194(6):2731-2746. PubMed ID: 35267120 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma. Tu K; Liu Z; Yao B; Han S; Yang W Int J Oncol; 2016 Mar; 48(3):965-74. PubMed ID: 26708293 [TBL] [Abstract][Full Text] [Related]
17. LINC00665 promotes the viability, migration and invasion of T cell acute lymphoblastic leukemia cells by targeting miR-101 via modulating PI3K/Akt pathway. Abuduer M; A EZG Tissue Cell; 2021 Aug; 71():101579. PubMed ID: 34171521 [TBL] [Abstract][Full Text] [Related]
18. miR-382-5p promotes cell invasion in hepatocellular carcinoma by targeting PTEN to activate PI3K/Akt signaling pathway. Lv B; Liu X; Zhu X; Huang M World J Surg Oncol; 2022 Jun; 20(1):175. PubMed ID: 35655254 [TBL] [Abstract][Full Text] [Related]
19. DUXAP10 inhibition attenuates the proliferation and metastasis of hepatocellular carcinoma cells by regulation of the Wnt/β-catenin and PI3K/Akt signaling pathways. Han K; Li C; Zhang X; Shang L Biosci Rep; 2019 May; 39(5):. PubMed ID: 30996112 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway. Li WF; Dai H; Ou Q; Zuo GQ; Liu CA Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]